Published in BMJ on July 14, 2009
Trends in age-specific coronary heart disease mortality in the European Union over three decades: 1980-2009. Eur Heart J (2013) 2.74
Cardiovascular health behavior and health factor changes (1988-2008) and projections to 2020: results from the National Health and Nutrition Examination Surveys. Circulation (2012) 2.59
Short term impact of smoke-free legislation in England: retrospective analysis of hospital admissions for myocardial infarction. BMJ (2010) 1.95
Persistent socioeconomic inequalities in cardiovascular risk factors in England over 1994-2008: a time-trend analysis of repeated cross-sectional data. BMC Public Health (2012) 1.41
Changing trends in the prevalence and disparities of obesity and other cardiovascular disease risk factors in three racial/ethnic groups of USA adults. Adv Prev Med (2012) 1.30
Socioeconomic deprivation and the incidence of 12 cardiovascular diseases in 1.9 million women and men: implications for risk prediction and prevention. PLoS One (2014) 1.15
Trends in adult cardiovascular disease risk factors and their socio-economic patterning in the Scottish population 1995-2008: cross-sectional surveys. BMJ Open (2011) 1.10
Unequal trends in coronary heart disease mortality by socioeconomic circumstances, England 1982-2006: an analytical study. PLoS One (2013) 1.04
Continuing decrease in coronary heart disease mortality in Sweden. BMC Cardiovasc Disord (2014) 0.98
Age-specific trends in cardiovascular mortality rates in the Netherlands between 1980 and 2009. Eur J Epidemiol (2011) 0.96
Thirty-year (1975 to 2005) trends in the incidence rates, clinical features, treatment practices, and short-term outcomes of patients <55 years of age hospitalized with an initial acute myocardial infarction. Am J Cardiol (2011) 0.92
Early life socioeconomic adversity is associated in adult life with chronic inflammation, carotid atherosclerosis, poorer lung function and decreased cognitive performance: a cross-sectional, population-based study. BMC Public Health (2011) 0.92
Future declines of coronary heart disease mortality in England and Wales could counter the burden of population ageing. PLoS One (2014) 0.89
Trends in cardiovascular disease biomarkers and their socioeconomic patterning among adults in the Scottish population 1995 to 2009: cross-sectional surveys. BMJ Open (2012) 0.84
Trends in age-standardised and age-specific mortality from ischaemic heart disease in Germany. Clin Res Cardiol (2010) 0.83
Why has mortality from coronary heart disease in young adults levelled off? BMJ (2009) 0.78
Decline in Cardiovascular Mortality: Possible Causes and Implications. Circ Res (2017) 0.75
Variations in vascular mortality trends, 2001-2010, among 1.3 million women with different lifestyle risk factors for the disease. Eur J Prev Cardiol (2014) 0.75
Prevalence and trends in obesity among US adults, 1999-2000. JAMA (2002) 33.23
Coronary heart disease mortality among young adults in the U.S. from 1980 through 2002: concealed leveling of mortality rates. J Am Coll Cardiol (2007) 7.13
Widening socioeconomic inequalities in mortality in six Western European countries. Int J Epidemiol (2003) 6.95
Socioeconomic status and trends in disparities in 4 major risk factors for cardiovascular disease among US adults, 1971-2002. Arch Intern Med (2006) 4.17
Coronary heart disease trends in England and Wales from 1984 to 2004: concealed levelling of mortality rates among young adults. Heart (2007) 3.29
The Index of Multiple Deprivation 2000 and accessibility effects on health. J Epidemiol Community Health (2004) 2.92
Trends and cardiovascular mortality effects of state-level blood pressure and uncontrolled hypertension in the United States. Circulation (2008) 2.65
Measuring outcomes: one month survival after acute myocardial infarction in Scotland. Heart (1996) 2.30
"I don't like Mondays"-day of the week of coronary heart disease deaths in Scotland: study of routinely collected data. BMJ (2000) 2.25
Age, sex, and social trends in out-of-hospital cardiac deaths in Scotland 1986-95: a retrospective cohort study. Lancet (2001) 1.96
An update on regional variation in cardiovascular mortality within Europe. Eur Heart J (2008) 1.83
The falling mortality from coronary heart disease: a clinicopathological perspective. The United Kingdom Heart Attack Study (UKHAS) Collaborative Group. Heart (1998) 1.79
How low can it go? Projecting ischaemic heart disease mortality in New Zealand to 2015. N Z Med J (2006) 1.74
Widening of socioeconomic inequalities in U.S. death rates, 1993-2001. PLoS One (2008) 1.74
Social distribution of cardiovascular disease risk factors: change among men in England 1984-1993. J Epidemiol Community Health (2000) 1.43
Life-years gained from coronary heart disease mortality reduction in Scotland: prevention or treatment? J Clin Epidemiol (2003) 1.33
The role of conventional risk factors in explaining social inequalities in coronary heart disease: the relative and absolute approaches to risk. Epidemiology (2008) 1.16
Changes in traditional risk factors no longer explain time trends in cardiovascular mortality and its socioeconomic differences. J Epidemiol Community Health (2008) 1.14
Coronary heart disease mortality in Australia: is mortality starting to increase among young men? Int J Epidemiol (1995) 1.10
Sociodemographic differences in exposure to health information. Ethn Dis (2002) 1.08
Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med (2007) 16.95
Coronary heart disease mortality among young adults in the U.S. from 1980 through 2002: concealed leveling of mortality rates. J Am Coll Cardiol (2007) 7.13
Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation (2004) 6.46
Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA (2003) 5.32
Effectiveness and cost effectiveness of cardiovascular disease prevention in whole populations: modelling study. BMJ (2011) 3.86
The current cost of heart failure to the National Health Service in the UK. Eur J Heart Fail (2002) 3.17
How much of the recent decline in the incidence of myocardial infarction in British men can be explained by changes in cardiovascular risk factors? Evidence from a prospective population-based study. Circulation (2008) 3.13
Outcomes of elective induction of labour compared with expectant management: population based study. BMJ (2012) 3.07
Modelling the decreasing coronary heart disease mortality in Sweden between 1986 and 2002. Eur Heart J (2009) 2.89
Explaining the increase in coronary heart disease mortality in Beijing between 1984 and 1999. Circulation (2004) 2.81
Association of temporal trends in risk factors and treatment uptake with coronary heart disease mortality, 1994-2005. JAMA (2010) 2.61
Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people. Circulation (2009) 2.60
Cardiovascular health behavior and health factor changes (1988-2008) and projections to 2020: results from the National Health and Nutrition Examination Surveys. Circulation (2012) 2.59
Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997. Am J Epidemiol (2005) 2.43
The use of research evidence in public health decision making processes: systematic review. PLoS One (2011) 2.32
Proportion of the decline in cardiovascular mortality disease due to prevention versus treatment: public health versus clinical care. Annu Rev Public Health (2011) 2.24
Cerebral palsy and intrauterine growth in single births: European collaborative study. Lancet (2003) 2.11
Analysing recent socioeconomic trends in coronary heart disease mortality in England, 2000-2007: a population modelling study. PLoS Med (2012) 2.07
Validation of three-dimensional model-based tibio-femoral tracking during running. Med Eng Phys (2008) 1.92
Policy options to reduce population salt intake. BMJ (2011) 1.91
Healthy lifestyle behaviors and all-cause mortality among adults in the United States. Prev Med (2012) 1.87
Trends in the prevalence of low risk factor burden for cardiovascular disease among United States adults. Circulation (2009) 1.83
Remarkable decline in ischemic stroke mortality is not matched by changes in incidence. Stroke (2012) 1.79
Does an advanced life support course give non-anaesthetists adequate skills to manage an airway? Resuscitation (2010) 1.78
Doctors' perceptions of palliative care for heart failure: focus group study. BMJ (2002) 1.73
Junctional adhesion molecule-1 is upregulated in spontaneously hypertensive rats: evidence for a prohypertensive role within the brain stem. Hypertension (2007) 1.73
Decline in mortality from coronary heart disease in Poland after socioeconomic transformation: modelling study. BMJ (2012) 1.69
Endothelial NO synthase activity in nucleus tractus solitarii contributes to hypertension in spontaneously hypertensive rats. Hypertension (2006) 1.68
Population-based trends in pregnancy hypertension and pre-eclampsia: an international comparative study. BMJ Open (2011) 1.64
Subversion of the innate immune system by a retrovirus. Nat Immunol (2003) 1.63
Ovulation induction/intrauterine insemination in infertile couples is associated with low-birth-weight infants. Am J Obstet Gynecol (2003) 1.58
Life-years gained from modern cardiological treatments and population risk factor changes in England and Wales, 1981-2000. Am J Public Health (2005) 1.57
Centile charts for birthweight for gestational age for Scottish singleton births. BMC Pregnancy Childbirth (2008) 1.57
Country actions to meet UN commitments on non-communicable diseases: a stepwise approach. Lancet (2013) 1.55
Explaining the decrease in coronary heart disease mortality in Italy between 1980 and 2000. Am J Public Health (2009) 1.51
Modelling the impact of a healthy diet on cardiovascular disease and cancer mortality. J Epidemiol Community Health (2010) 1.50
[Analyzing the coronary heart disease mortality decline in a Mediterranean population: Spain 1988-2005]. Rev Esp Cardiol (2011) 1.48
Community care in England: reducing socioeconomic inequalities in heart failure. Circulation (2012) 1.47
Seasonal variation in morbidity and mortality related to atrial fibrillation. Int J Cardiol (2004) 1.46
Contributions of treatment and lifestyle to declining CVD mortality: why have CVD mortality rates declined so much since the 1960s? Heart (2012) 1.45
Explaining the recent decrease in coronary heart disease mortality rates in Ireland, 1985-2000. J Epidemiol Community Health (2006) 1.43
Persistent socioeconomic inequalities in cardiovascular risk factors in England over 1994-2008: a time-trend analysis of repeated cross-sectional data. BMC Public Health (2012) 1.41
The effect of changing patterns of obstetric care in Scotland (1980-2004) on rates of preterm birth and its neonatal consequences: perinatal database study. PLoS Med (2009) 1.38
The comparative effectiveness of heart disease prevention and treatment strategies. Am J Prev Med (2009) 1.36
Mammary alveolar development during lactation is inhibited by the endogenous antiangiogenic growth factor isoform, VEGF165b. FASEB J (2007) 1.34
Deficient activity in the neural systems that mediate self-regulatory control in bulimia nervosa. Arch Gen Psychiatry (2009) 1.34
Patterns of coronary heart disease mortality over the 20th century in England and Wales: Possible plateaus in the rate of decline. BMC Public Health (2008) 1.32
Analysing the large decline in coronary heart disease mortality in the Icelandic population aged 25-74 between the years 1981 and 2006. PLoS One (2010) 1.32
A comprehensive description of the transcriptome of the hypothalamoneurohypophyseal system in euhydrated and dehydrated rats. Proc Natl Acad Sci U S A (2006) 1.31
Why are patients in clinical trials of heart failure not like those we see in everyday practice? J Clin Epidemiol (2003) 1.31
Coronary heart disease policy models: a systematic review. BMC Public Health (2006) 1.31
Re-evaluating the Rose approach: comparative benefits of the population and high-risk preventive strategies. Eur J Cardiovasc Prev Rehabil (2009) 1.28
Transgenic expression of enhanced green fluorescent protein enables direct visualization for physiological studies of vasopressin neurons and isolated nerve terminals of the rat. Endocrinology (2004) 1.28
Heart failure and socioeconomic status: accumulating evidence of inequality. Eur J Heart Fail (2012) 1.27
A study of the response of the human cadaver head to impact. Stapp Car Crash J (2007) 1.26
Coronary mortality declines in the U.S. between 1980 and 2000 quantifying the contributions from primary and secondary prevention. Am J Prev Med (2010) 1.24
What explains declining coronary mortality? Lessons and warnings. Heart (2008) 1.24
The decline in coronary heart disease mortality is slowing in young adults (Australia 1976-2006): a time trend analysis. Int J Cardiol (2011) 1.23
Heart failure in a cold climate. Seasonal variation in heart failure-related morbidity and mortality. J Am Coll Cardiol (2002) 1.23
Planning ahead in public health? A qualitative study of the time horizons used in public health decision-making. BMC Public Health (2008) 1.21
Quantifying options for reducing coronary heart disease mortality by 2020. Circulation (2013) 1.20
Avian influenza H5N1: risks at the human-animal interface. Food Nutr Bull (2007) 1.18
The complex nature of informal care in home-based heart failure management. J Adv Nurs (2008) 1.17
Small changes in United Kingdom cardiovascular risk factors could halve coronary heart disease mortality. J Clin Epidemiol (2005) 1.17
Sex differences in incidence, mortality, and survival in individuals with stroke in Scotland, 1986 to 2005. Stroke (2009) 1.15
Estimating the impact of stroke unit care in a whole population: an epidemiological study using routine data. J Neurol Neurosurg Psychiatry (2010) 1.13
Social fragmentation, deprivation and urbanicity: relation to first-admission rates for psychoses. Br J Psychiatry (2005) 1.13
Doctors' understanding of palliative care. Palliat Med (2006) 1.12
Population trends and inequalities in incidence and short-term outcome of acute myocardial infarction between 1998 and 2007. Int J Cardiol (2012) 1.11
Trends in adult cardiovascular disease risk factors and their socio-economic patterning in the Scottish population 1995-2008: cross-sectional surveys. BMJ Open (2011) 1.10
Automation of analysis of cardiovascular autonomic function from chronic measurements of arterial pressure in conscious rats. Exp Physiol (2005) 1.08
Salt: the dying echoes of the food industry. Am J Hypertens (2013) 1.08
United Nations' dietary policies to prevent cardiovascular disease. BMJ (2011) 1.07
Microarray analysis reveals interleukin-6 as a novel secretory product of the hypothalamo-neurohypophyseal system. J Biol Chem (2003) 1.07
The impact of demographic and risk factor changes on coronary heart disease deaths in Beijing, 1999-2010. BMC Public Health (2009) 1.05
Estimating the cardiovascular mortality burden attributable to the European Common Agricultural Policy on dietary saturated fats. Bull World Health Organ (2008) 1.05
Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer. Genome Biol (2014) 1.04
Mortality reductions in patients receiving exercise-based cardiac rehabilitation: how much can be attributed to cardiovascular risk factor improvements? Eur J Cardiovasc Prev Rehabil (2006) 1.04
Unequal trends in coronary heart disease mortality by socioeconomic circumstances, England 1982-2006: an analytical study. PLoS One (2013) 1.04
Effectiveness and safety of chest pain assessment to prevent emergency admissions: ESCAPE cluster randomised trial. BMJ (2007) 1.03
Potential cardiovascular mortality reductions with stricter food policies in the United Kingdom of Great Britain and Northern Ireland. Bull World Health Organ (2012) 1.02
Policy-makers' attitudes to decision support models for coronary heart disease: a qualitative study. J Health Serv Res Policy (2008) 1.02
An affective-cognitive processing model of post-traumatic growth. Clin Psychol Psychother (2012) 1.01
A novel antiandrogen, Compound 30, suppresses castration-resistant and MDV3100-resistant prostate cancer growth in vitro and in vivo. Mol Cancer Ther (2013) 1.01
Modelling the impact of specific food policy options on coronary heart disease and stroke deaths in Ireland. BMJ Open (2013) 1.01
Modelling Coronary Heart Disease Mortality declines in the Republic of Ireland, 1985-2006. Int J Cardiol (2013) 1.00
Population-level changes to promote cardiovascular health. Eur J Prev Cardiol (2012) 1.00
Activation of protein kinase Czeta is essential for cytokine-induced metalloproteinase-1, -3, and -9 secretion from rabbit smooth muscle cells and inhibits proliferation. J Biol Chem (2002) 1.00
Pulmonary arterial pulse pressure and mortality in pulmonary arterial hypertension. Respir Med (2007) 0.99
Analyzing recent coronary heart disease mortality trends in Tunisia between 1997 and 2009. PLoS One (2013) 0.99
Addictive potential of quetiapine. Am J Psychiatry (2008) 0.99
Continuing decrease in coronary heart disease mortality in Sweden. BMC Cardiovasc Disord (2014) 0.98
Heterogeneity in ess transcriptional organization and variable contribution of the Ess/Type VII protein secretion system to virulence across closely related Staphylocccus aureus strains. Mol Microbiol (2014) 0.98
Trends in total and low-density lipoprotein cholesterol among U.S. adults: contributions of changes in dietary fat intake and use of cholesterol-lowering medications. PLoS One (2013) 0.98
Chronic inhibition of endothelial nitric oxide synthase activity in nucleus tractus solitarii enhances baroreceptor reflex in conscious rats. J Physiol (2003) 0.97